Hopp til hovedinnhold
Årsaken til eosinofil øsofagitt synes å være en allergisk reaksjon på innholdsstoffer i mat.
Årsaken til eosinofil øsofagitt synes å være en allergisk reaksjon på innholdsstoffer i mat.

Allergisk betennelse i spiserøret - eosinofil øsofagitt

Allergisk betennelse i spiserøret gir plager som ligner på syreplager, men symptomene forsvinner ikke med syrehemmende behandling.

Sist revidert:

QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/allergi/diverse/allergi-i-spiseroret/ 

Hva er allergisk reaksjon i spiserøret?

Årsak

Symptomer

Diagnosen

Behandling

Prognose

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Eosinofil øsofagitt. Referanselisten for dette dokumentet vises nedenfor.

  1. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128:3. PubMed 
  2. Furuta GT, Katzka DA. Eosinophilic esophagitis. N Engl J Med 2015; 373:1640. New England Journal of Medicine 
  3. Carlson M, Dlugosz A. Utredning och behandling av esosinofil esofagit. Svensk Gastroenterologisk Förening, 2020.
  4. Desai TK, Stecevic V, Chang C, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointestinal Endoscopy 2005; 61: 795-801. PubMed 
  5. Bonis PAL, Gupta SK. Clinical manifestations and diagnosis of eosinophilic esophagitis. UpToDate, last updated Feb 17, 2020. UpToDate 
  6. Arias Á, Lucendo AJ. Incidence and prevalence of eosinophilic oesophagitis increase continiously in adults and children in Central Spain: A 12-year population-based study. Dig Liver Dis. 2019;51(1):55-62. PubMed 
  7. Bonis PAL, Gupta SK. Treatment of eosinophilic esophagitis. UpToDate, last updated Feb 02, 2021. UpToDate 
  8. Holme Ø, Tjora E, Aabakken L. Eosinofil øsofagitt. Oversiktsartikkel. Tidsskr Nor Legeforen 2011; 131: 2470-4. doi:10.4045/tidsskr.11.0417 DOI 
  9. Wolf WA, Jerath MR, Sperry SL, et al. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12:1272-79 . PubMed 
  10. Dharmaraj R, Hagglund K, Lyons H. Eosinophilic esophagitis associated with celiac disease in children. BMC Research Notes 2015; 8: 263. doi:10.1186/s13104-015-1256-z DOI 
  11. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3. PubMed 
  12. Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology 2014; 147: 1238-54. pmid:25109885 PubMed 
  13. Dellon ES, Rusin S, Gebhart JH, et al. Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study. Am J Gastroenterol. 2015. DOI:10.1038/ajg.2015.57. DOI 
  14. Kliewer KL, Gonsalves N, Dellon ES, et al. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. Lancet Gastroenterol Hepatol 2023. pmid:36863390 PubMed 
  15. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133: 1342-63. Gastroenterology 
  16. Lucendo AJ, Miehlke S, Schlag C, et al. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial. Gastroenterology. 2019;157(1):74-86.e15. PMID: 30922997. PubMed 
  17. Straumann A, Lucendo AJ, Miehlke S, et al. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis. Gastroenterology. 2020;159(5):1672-1685.e5. PMID: 32721437. PubMed 
  18. Vazquez-Elizondo G, Ngamruengphong S, Khrisna M, et al. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther 2013; 38:1312. PubMed 
  19. Dellon ES, Rothenberg ME, Collins MH, et al. Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis. N Engl J Med 2022; 387: 2317-2330. pmid:36546624 PubMed 
  20. Zimmerman SL, Levine MS, Rubesin SE, et al. Idiopathic eosinophilic esophagitis in adults: the ringed esophagus. Radiology 2005; 236: 159-65. Radiology